AstraZeneca Surges as Oncology Sales Drive Q4 Earnings Beat, Solid 2019 Outlook

AstraZeneca Surges as Oncology Sales Drive Q4 Earnings Beat, Solid 2019 Outlook

AstraZeneca shares traded sharply higher Thursday after the U.K.-based drugmaker posted stronger-than-forecast fourth quarter earnings, and said 2019 revenues would continue to rise, thanks to increasing demand for its key cancer treatments.

Airbus Soars to Record High After Q4 Earnings Beat, A380 Program Closure

Airbus Soars to Record High After Q4 Earnings Beat, A380 Program Closure

Airbus shares traded at an all-time high Thursday after the Franco-German planemaker and key Boeing rival posted stronger-than-expected fourth quarter earnings, issued a robust 2019 outlook for aircraft deliveries and said it would formally scrap it struggling A380 jumbo jet program.

Huntington Ingalls Expected to Earn $4.51 a Share

Huntington Ingalls Expected to Earn $4.51 a Share

Huntington Ingalls revenue expected to rise 1.9% to $2 billion.

CME Group Revenue Expected to Rise 33.4% to $1.2 billion

CME Group Revenue Expected to Rise 33.4% to $1.2 billion

Earnings per share expected to hit $1.73 at futures exchange operator.

Incyte Expected to Earn 17 Cents a Share

Incyte Expected to Earn 17 Cents a Share

Incyte revenue expected to rise 9.5% to $486.2 million.

Quest Diagnostics Expected to Earn $1.37 a Share

Quest Diagnostics Expected to Earn $1.37 a Share

Revenue expected to fall 3% to $1.9 billion for medical services provider.

Cisco Climbs on Q4 Earnings, Dividend Increase and $15 Billion Stock Buyback

Cisco Climbs on Q4 Earnings, Dividend Increase and $15 Billion Stock Buyback

Cisco beat earnings expectations by a penny and issued strong guidance for the current quarter.

Two Dividend Stocks I Own and One I'm Looking to Buy

Two Dividend Stocks I Own and One I'm Looking to Buy

These stocks aren't going out of style.

Natus Medical Falls Sharply After Earnings Come Up Short

Natus Medical Falls Sharply After Earnings Come Up Short

Shares of Natus Medical tumble after the newborn medical device maker misses Wall Street's fourth-quarter earnings and 2019 guidance expectations.

What Is Switching Investors on to Cisco Stock?

What Is Switching Investors on to Cisco Stock?

Cisco could surge with these key catalysts and indicators switched on.